NEW ISSUE
EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…
July 20, 2021
Showing 1-6 of 6 articles
Reference dimensions of stented surgical aortic bioprostheses for valve size determination
August 7, 2020 | 10.4244/EIJ-D-19-00921
Interventions for valvular disease
Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions February 7, 2020 | 10.4244/EIJ-D-19-00782
Interventions for valvular disease
Early experience with a purpose-designed temporary pacing guidewire for transcatheter valve implantation August 9, 2019 | 10.4244/EIJ-D-19-00138
Interventions for valvular disease
Impact of implant depth on hydrodynamic function with the ACURATE neo transcatheter heart valve following valve-in-valve transcatheter aortic valve replacement in Mitroflow bioprosthetic valves: an ex vivo bench study May 20, 2019 | 10.4244/EIJ-D-18-00947
Interventions for valvular disease
First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system February 7, 2019 | 10.4244/EIJ-D-18-00935
Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation Study
June 14, 2018 | 10.4244/EIJ-D-18-00346